The low affinity glutamate NMDA receptor antagonist memantine can slightly reduce deterioration in patients with moderate to severe Alzheimer’s disease, but the effect in less severely affected people is unknown.
Arena Pharmaceuticals Inc. said its experimental obesity drug was effective in helping patients lose weight in a short-term, mid-stage clinical trial, sending its shares up more than 22 percent.
Postmenopausal women who have survived early breast cancer face a higher than average risk of osteoporosis, according to a report by Canadian researchers.
The Food and Drug Administration has approved Requip (ropinirole) to treat moderate to severe Restless Legs Syndrome (RLS). The drug was first approved for Parkinson?s disease in 1997.
The Fundamental Principles of Homoeopathy are well known to all Homoeopathic Physicians. But, as they say, it becomes a difficult task to stick to them when you are posted in a rural backdrop or when posted in a dispensary and lots of patients have to be seen- and you can’t devote more than 3-4 minutes on every patient. So, many people told me, but when I also got posted in this rural dispensary some of my friends said let us see how you can follow the path of mono and mini medicines.
A study has found that the ancient Chinese practice is as effective as popular painkillers for treating disabling conditions such as arthritis.
Dietary supplementation with omega-3 and other fatty acids appears to reduce the educational and behavioral problems of children with a condition termed developmental coordination disorder (DCD), UK researchers report.
Lifestyle changes are more effective than drug treatment in preventing metabolic syndrome, the cluster of disorders that can lead to diabetes and heart disease, according to a new study.
The Food and Drug Administration (FDA) today issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved (i.e., off-label) use of certain drugs called atypical antipsychotic drugs. These drugs are approved for the treatment of schizophrenia and mania, but clinical studies of these drugs to treat behavioral disorders in elderly patients with dementia have shown a higher death rate associated with their use compared to patients receiving a placebo (sugar pill).
People with diabetes are 1.6 times more likely to seek out complementary and alternative medicine than those in the general population. That’s the conclusion of a recent study from the Medical University of South Carolina based on information from a nationally representative sample of the US population.